期刊文献+

乙型肝炎肝硬化代偿期采用软肝化瘀汤的临床效果分析 被引量:3

Clinical Effect Analysis of Softening Liver and Removing Blood Stasis Decoction for Hepatitis B Cirrhosis in Compensation Period
下载PDF
导出
摘要 目的分析乙型肝炎肝硬化代偿期采用软肝化瘀汤的临床效果。方法对照组实施常规保肝、抗病毒治疗,观察组在对照组基础上予以软肝化瘀汤治疗。观察治疗效果、中医证候积分、肝功能指标、凝血指标。结果观察组总有效率及治疗后的中医证候积分、肝功能指标,显著优于对照组(P<0.05)。结论乙型肝炎肝硬化代偿期采用软肝化瘀汤的临床效果良好,在改善临床症状及肝功能均可获得明显的效果。 Objective To analyze clinical effect of softening liver and removing blood stasis decoction in compensatory period of hepatitis B cirrhosis. Methods Control group was treated with routine hepatoprotective and antiviral therapy, while observation group with softening liver and removing blood stasis decoction on the basis of control group. Observe curative effect, TCM syndrome integral, liver function index and coagulation index of two groups. Results Total effective rate, TCM syndrome scores and liver function index of observation group were better than control group significantly(P<0.05). Conclusion Softening liver and removing blood stasis decoction has good clinical effect on compensatory period of hepatitis B cirrhosis, with obvious effect to improve clinical symptoms and liver function.
作者 黄迎春 HUANG Ying-chun(Internal Medicine Department,Beijing the First Integrated Chinese and Western Medicine Hospital,Beijing,100018)
出处 《智慧健康》 2019年第30期165-166,共2页 Smart Healthcare
关键词 乙型肝炎 肝硬化 代偿期 软肝化瘀汤 Hepatitis B Liver cirrhosis Compensation period Softening liver and removing blood stasis decoction
  • 相关文献

参考文献6

二级参考文献21

  • 1危北海,张万岱,陈治水,张育轩.肝硬化中西医结合诊治方案[J].现代消化及介入诊疗,2005,10(2):119-121. 被引量:93
  • 2病毒性肝炎防治方案(试行)[J].中西医结合肝病杂志,1996,6(1):50-53. 被引量:136
  • 3Henderson N C, Iredale J P. Liver fibrosis : cellularmechanisms of pro- gression and resolution. Clin Sci,2007, 112 (5) : 265.
  • 4Rob Inson D M, Scott L I, PLOSKER G L. Entecavir areview of its use in chronic hepatitis B. Drugs, 2006, 66(12) : 1605.
  • 5Fr Iedman S L. Mechanisms of hepatic fibrosis and the 2rapeutic implica- tion. Nat Clin Pract Gastroenterol Hepatol, 2004,1 (2) :98.
  • 6Younossi Z M,Guyatt G,Kiwi M,et al.Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut . 1999
  • 7Nath N C,Rahman M A,Khan M R,Hasan M S,Bhuiyan T M,Hoque M N,Kabir M M,Raha A K,Jahan B.Serum hyaluronic acid as a predictor of fibrosis in chronic hepatitis B and C virus infection. Mymensingh medical journal : MMJ . 2011
  • 8王吉耀,廖二元,王辰.内科学[M].3版.北京:人民卫生出版社,2015:1203-1205.
  • 9沈吉云,燕忠生.丹参保肝抗肝纤维化药理作用及应用进展[J].中西医结合肝病杂志,1998,8(2):324-326. 被引量:54
  • 10郭威,周莹,鲁有水,高斯媛,钱冬斌.恩替卡韦联合安络化纤丸治疗慢性乙型肝炎肝纤维化43例[J].医药导报,2010,29(9):1157-1159. 被引量:20

共引文献31

同被引文献35

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部